
Through digital media and technology, the patient’s voice is only growing in strength and it is of growing importance that …

Researchers have found that offering first-time patients a HIV test in an area of high-prevalence could help reduce levels of …

Still reeling from the public reaction to the flop of its key Mystic trial, where its injectable immunotherapy drug Imfinzi …

The FDA has reputation worldwide as being a standard bearer when it comes to regulating the safety of products and …

Sanofi exuded renewed confidence in its updated forecast for 2017 on the back of a Q2 report which illustrated strong …

Jeremy Hunt has unveiled a plan to boost recruitment of mental health staff by using £1 billion in funds to …

A study published in the BMJ displayed the large degree of variation and lack of industry-standard when it comes to …

Pharmafile spoke to National Cancer Institute’s (NCI) Jason Christofaro and Sherry Ansher regarding the development of an agent formulary and its role …

It’s Friday, and it’s been a week characterised by a range of promising research results, particularly into HIV and Duchenne …

The WHO has released a report on the state of hepatitis prevention and treatment to mark World Hepatitis Day, with …

The EMA has announced its intention to introduce revised guidelines concerning the use of medicines in first in-human clinical trials …

In what will be regarded as a watershed moment, scientists working at Oregon Health and Science University have used CRISPR …

GSK has created a whole new role to push the company to strengthen its digital, data and analytics strategy, with …

The UK Government has announced a new appointment within the Department of Health: Steve Oldfield, a former veteran of Teva …

It will be some time before the Mystic catastrophe hoo-ha dies down for AstraZeneca but it made a pre-emptive move …